1Hematology Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Recombinant human erythropoietin (rhEpo) therapy effectively treats anemia in chronic kidney disease and other conditions. rhEpo is revolutionizing transfusion medicine by aiding autotransfusions and reducing post-operative transfusions.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: